EZH2 inhibition stimulates viral mimicry in resting splenic B cells
Abstract
In mammalian cells expression of repetitive genomic sequences is repressed by heterochromatin, underscoring the potential threat of repeat expression to cellular homeostasis. However, the specific consequences of ectopic repeat expression remains unclear. Here we demonstrate that EZH2 inhibitors stimulate repeat misexpression and cell death in resting splenic B cells. We show that B cells are uniquely sensitive to these agents because of high levels of H3K27me3 at repeats and correspondingly low DNA methylation. We generated a pattern recognition receptor loss-of-function mouse model called RIC with mutations in Rigi, Ifih1 (MDA5), and Cgas to specifically block the consequences of repeat misexpression. In both WT and RIC mutant B cells, EZH2 inhibition caused focused loss of H3K27me3 at repetitive elements and upregulated their expression. However, expression of inflammatory chemokines and cell death were interrupted by the RIC mutations. Furthermore, the chemokine expression patterns induced by EZH2 inhibitors resemble the B cell response to Epstein-Barr virus infection. This study demonstrates a viral mimicry effect induced by pharmacological activation of repeat expression that induces inflammation and B cell death.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Transient EZH2 suppression by Tazemetostat during in vitro expansion maintains T cell stemness and improves adoptive T cell therapy
- Ezh2 knockout in B cells impairs plasmablast differentiation and ameliorates lupus-like disease in MRL/lpr mice
X. Zheng, M. G. Dozmorov, … A. H. Sawalha·bioRxiv·Jul 21, 2022
- EZH2 inhibition results in genome-wide PRC2 redistribution
Chih-Chi Yuan, Ah‐Jung Jeon, … Patrick Trojer·bioRxiv·Dec 29, 2019
- Increased EZH2 function in regulatory T cells promotes their capacity to suppress autoimmunity by driving effector differentiation prior to activation
Janneke G. C. Peeters, Stephanie L. Silveria, … Michel J.P. DuPage·Cell ReportsPeer-reviewed·Sep 1, 2024
- Epigenetic vulnerabilities of leukemia harboring inactivating EZH2 mutations
M. Alqazzaz, G. Luciani, … D. Barsyte-Lovejoy·bioRxiv·Nov 20, 2023
- Inhibition of EZH2 ameliorates lupus-like disease in MRL/lpr mice
D. M. Rohraff, Y. He, … A. H. Sawalha·bioRxiv·Dec 25, 2018